Covidien receives FDA clearance for LigaSure Maryland jaw Covidien received U.S. Food and Drug Administration 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic sealer/divider. In addition, Covidien completed all European requirements to CE Mark the product. The company expects to launch the new vessel sealer and divider in the U.S. and the European Union during the current quarter. Covidien plans to roll out the 37 cm version to select customers early in 2014 and launch the shorter 23 cm and longer 44 cm options later this year.
News For COV From The Last 14 Days
Check below for free stories on COV the last two weeks.
Covidien sees long-term double digit EPS growth Other long term goals include: Mid-single digit sales growth, returning cash to shareholders, leveraging cash flow for long-term profitable growth. Comments from slides that were presented at the Raymond James Institutional Investors Conference.
Covidien announces CE Mark approval for Puritan Bennett 980 ventilator Covidien announced its Puritan Bennett 980 ventilator has received European Economic Area CE Mark approval. The Puritan Bennett 980 ventilator system is for patients ranging from neonatal to adult. The ventilator system was also approved for commercial distribution in the U.S., Japan and Canada and will be available for sale in those countries as well as the EEA in the coming months.